Genomictree (228760.KQ) Earnings Analysis
Genomictree (228760.KQ) has no confirmed upcoming earnings date. Trailing P/E -36.92.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 228760.KQ next report earnings?
No confirmed upcoming earnings date is currently scheduled for 228760.KQ. This page updates as the calendar is published.
228760.KQ earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-09 | -80.75 KRW | n/a | n/a | n/a |
| 2024-12-31 | -71.63886 KRW | n/a | n/a | n/a |
| 2024-09-30 | -129 KRW | n/a | n/a | n/a |
228760.KQ valuation and analyst view
| Trailing P/E | -36.92 |
|---|---|
| Trailing EPS | -330.09451 KRW |
| Price / book | 2.43 |
| Dividend yield | 0.00% |
| Market cap | 278.38B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Genomictree (228760.KQ)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 228760.KQ. This page updates as the calendar is published.
Did 228760.KQ beat earnings last quarter?
Consensus estimate data was not available for 228760.KQ's 2026-02-09 report.
What is 228760.KQ's current P/E ratio and EPS?
228760.KQ trades at a trailing P/E of -36.92 on trailing EPS of -330.0945050009363 KRW.
What do analysts rate 228760.KQ?
228760.KQ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.